The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Nanomaterial Extracts Oils & Pollutants From Water, Study
Researchers report a new strategy for removing oils and other organic pollutants from water using a re-usable nanomaterial.
Turtle Shells Evolved By Recruiting Genes Involved In Limb Development
An international team of scientists has analyzed the genomes of two turtle species, shedding light on how the turtle’s shell may have evolved.
China’s Zongyi Group Invests In US-Based ContraFect Corporation
The Zongyi Group of China has invested US$8.6 million into US-based ContraFect Corporation as part of a US$9.5 million financing.
Giant Pandas Receive Counselling After 7.0 Magnitude Sichuan Earthquake
A powerful 7.0 magnitude earthquake that shook southwest China's Sichuan province on April 21 has traumatized its giant panda population.
Roche, Ascletis To Bring Hepatitis C Drug Danoprevir Into China
Roche and Ascletis have entered into a collaboration to develop and commercialize Roche's investigational Hepatitis C drug danoprevir in China.
Magic Glasses Cartoon Halved Worm Infections In Chinese Schoolchildren
Researchers in China and Australia have reported huge success with a cartoon DVD promoting hygiene across rural China.
Most Australians Unaware That Women’s Fertility Declines In Early 30s
Most Australians underestimate when fertility in both men and women starts to decline, a national survey has found.
Simple Tool Can Identify Rise In Sea Levels, Study
A team of researchers in Singapore and the United States has proposed a simple method to identify areas that are vulnerable to sea-level rise.
5 Take-Home Points From India’s Historic Novartis Patent Case
The Indian Supreme Court ruling dismissing a patent application by Novartis for a new version of its leukemia drug raises five important points, writes Arvind Subramanian.